• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

循环滋养细胞数量作为妊娠并发症的潜在标志物。

Circulating trophoblast numbers as a potential marker for pregnancy complications.

机构信息

School of Medicine, Baylor College of Medicine, Houston, Texas, USA.

Department of Obstetrics and Gynecology, Baylor College of Medicine, Houston, Texas, USA.

出版信息

Prenat Diagn. 2022 Aug;42(9):1182-1189. doi: 10.1002/pd.6202. Epub 2022 Jul 2.

DOI:10.1002/pd.6202
PMID:35765264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9710861/
Abstract

OBJECTIVE

To explore the potential of circulating trophoblasts (TBs) as a non-invasive tool to assess placental health and predict obstetric complications.

METHODS

We retrospectively reviewed maternal characteristics and pregnancy outcomes of 369 women who enrolled in our original cell-based NIPT (cbNIPT) study. The number of circulating TBs recovered from the maternal blood samples was recorded and expressed as fetal cell concentration (FCC). We evaluated if FCC can be used to predict pregnancy outcomes such as hypertensive disorders of pregnancy (HDP), fetal growth restriction, placental abruption, preterm labor, and pregnancy loss.

RESULTS

Receiver operating characteristic (ROC) analysis was performed to find the best cut off value to classify FCC into a low and high FCC group, and this cut-off point was calculated as 11.1 cells per 100 ml of blood. The adjusted odds ratio (aOR) for the composite morbidity was significantly increased for the high FCC group at an aOR of 1.6.

CONCLUSION

Circulating TB have the potential of predicting obstetrical complications such as HDP. Future studies, with larger sample sizes, should focus on the study of these cells as a biomarker for placental health and a possible screening or diagnostic tool for fetal genetic conditions.

摘要

目的

探讨循环滋养层细胞(TBs)作为一种非侵入性工具评估胎盘健康和预测产科并发症的潜力。

方法

我们回顾性分析了 369 名参加我们原始细胞为基础的无创性产前检测(cbNIPT)研究的女性的母体特征和妊娠结局。记录从母体血液样本中回收的循环 TBs 的数量,并表示为胎儿细胞浓度(FCC)。我们评估 FCC 是否可用于预测妊娠结局,如妊娠高血压疾病(HDP)、胎儿生长受限、胎盘早剥、早产和流产。

结果

进行了受试者工作特征(ROC)分析,以找到最佳的截断值将 FCC 分为低和高 FCC 组,该截断值计算为 11.1 个细胞/100ml 血液。对于高 FCC 组,复合发病率的调整优势比(aOR)显著增加,aOR 为 1.6。

结论

循环 TB 具有预测妊娠高血压疾病等产科并发症的潜力。未来的研究应着眼于这些细胞作为胎盘健康的生物标志物,并作为胎儿遗传疾病的可能筛查或诊断工具进行研究,样本量应更大。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fff/9710861/dd813125da8a/nihms-1845807-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fff/9710861/bf8eafe38094/nihms-1845807-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fff/9710861/61feecee4cad/nihms-1845807-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fff/9710861/3e8307073757/nihms-1845807-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fff/9710861/dd813125da8a/nihms-1845807-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fff/9710861/bf8eafe38094/nihms-1845807-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fff/9710861/61feecee4cad/nihms-1845807-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fff/9710861/3e8307073757/nihms-1845807-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3fff/9710861/dd813125da8a/nihms-1845807-f0004.jpg

相似文献

1
Circulating trophoblast numbers as a potential marker for pregnancy complications.循环滋养细胞数量作为妊娠并发症的潜在标志物。
Prenat Diagn. 2022 Aug;42(9):1182-1189. doi: 10.1002/pd.6202. Epub 2022 Jul 2.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
A prognostic model to guide decision-making on timing of delivery in late preterm pre-eclampsia: the PEACOCK prospective cohort study.一项用于指导晚期早产儿子痫前期分娩时机决策的预后模型:PEACOCK 前瞻性队列研究。
Health Technol Assess. 2021 May;25(30):1-32. doi: 10.3310/hta25300.
4
Lower fetal fraction in clinical cell-free DNA screening results is associated with increased risk of hypertensive disorders of pregnancy.临床游离胎儿 DNA 筛查结果中较低的胎儿分数与妊娠高血压疾病风险增加相关。
Prenat Diagn. 2022 Sep;42(10):1253-1261. doi: 10.1002/pd.6221. Epub 2022 Aug 22.
5
First-trimester maternal serum alpha fetoprotein is associated with ischemic placental disease.早孕期母血清甲胎蛋白与胎盘缺血性疾病相关。
Am J Obstet Gynecol. 2020 May;222(5):499.e1-499.e6. doi: 10.1016/j.ajog.2019.11.1264. Epub 2019 Nov 30.
6
The ability of late pregnancy maternal tests to predict adverse pregnancy outcomes associated with placental dysfunction (specifically fetal growth restriction and pre-eclampsia): a protocol for a systematic review and meta-analysis of prognostic accuracy studies.妊娠晚期母体检查预测胎盘功能障碍相关不良妊娠结局(特别是胎儿生长受限和子痫前期)的能力:系统评价和预后准确性研究荟萃分析的方案。
Syst Rev. 2020 Apr 8;9(1):78. doi: 10.1186/s13643-020-01334-5.
7
Fetal cell-free DNA fraction in maternal plasma for the prediction of hypertensive disorders of pregnancy.母体血浆中游离胎儿DNA比例用于预测妊娠期高血压疾病
Eur J Obstet Gynecol Reprod Biol. 2018 May;224:165-169. doi: 10.1016/j.ejogrb.2018.03.048. Epub 2018 Mar 26.
8
Angiogenic markers and their longitudinal change for predicting adverse outcomes in pregnant women with chronic hypertension.用于预测慢性高血压孕妇不良结局的血管生成标志物及其纵向变化。
Am J Obstet Gynecol. 2021 Sep;225(3):305.e1-305.e14. doi: 10.1016/j.ajog.2021.03.041. Epub 2021 Apr 1.
9
Pregnancy outcomes in nulliparous women with positive first-trimester preterm preeclampsia screening test: the Great Obstetrical Syndromes cohort study.初产妇中,早孕期子痫前期筛查阳性患者的妊娠结局:大型产科综合征队列研究。
Am J Obstet Gynecol. 2021 Feb;224(2):204.e1-204.e7. doi: 10.1016/j.ajog.2020.08.008. Epub 2020 Aug 7.
10
Adaptations of the human placenta to hypoxia: opportunities for interventions in fetal growth restriction.人类胎盘对缺氧的适应:干预胎儿生长受限的机会。
Hum Reprod Update. 2021 Apr 21;27(3):531-569. doi: 10.1093/humupd/dmaa053.

引用本文的文献

1
Cell-based Noninvasive Prenatal Testing (cbNIPT)-A Review on the Current Developments and Future Prospects.基于细胞的无创性产前检测 (cbNIPT)——当前发展与未来展望的综述。
Clin Obstet Gynecol. 2023 Sep 1;66(3):636-648. doi: 10.1097/GRF.0000000000000798. Epub 2023 Jul 17.
2
Whole-Chromosome Karyotyping of Fetal Nucleated Red Blood Cells Using the Ion Proton Sequencing Platform.利用 Ion Proton 测序平台对胎儿有核红细胞进行全染色体组染色体核型分析。
Genes (Basel). 2022 Nov 30;13(12):2257. doi: 10.3390/genes13122257.

本文引用的文献

1
RNA profiles reveal signatures of future health and disease in pregnancy.RNA 谱揭示了妊娠中未来健康和疾病的特征。
Nature. 2022 Jan;601(7893):422-427. doi: 10.1038/s41586-021-04249-w. Epub 2022 Jan 5.
2
Circulating trophoblast cell clusters for early detection of placenta accreta spectrum disorders.循环滋养细胞簇用于早期检测胎盘部位滋养细胞疾病谱。
Nat Commun. 2021 Aug 3;12(1):4408. doi: 10.1038/s41467-021-24627-2.
3
A literature review and best practice advice for second and third trimester risk stratification, monitoring, and management of pre-eclampsia: Compiled by the Pregnancy and Non-Communicable Diseases Committee of FIGO (the International Federation of Gynecology and Obstetrics).
子痫前期孕中期和孕晚期风险分层、监测及管理的文献综述与最佳实践建议:由国际妇产科联盟(FIGO)妊娠与非传染性疾病委员会编撰
Int J Gynaecol Obstet. 2021 Jul;154 Suppl 1(Suppl 1):3-31. doi: 10.1002/ijgo.13763.
4
Overview and recent developments in cell-based noninvasive prenatal testing.基于细胞的非侵入性产前检测的概述及最新进展。
Prenat Diagn. 2021 Sep;41(10):1202-1214. doi: 10.1002/pd.5957. Epub 2021 May 18.
5
Association of Circulating miRNA Expression with Preeclampsia, Its Onset, and Severity.循环miRNA表达与子痫前期及其发病和严重程度的关联。
Diagnostics (Basel). 2021 Mar 8;11(3):476. doi: 10.3390/diagnostics11030476.
6
Cell-based non-invasive prenatal testing for monogenic disorders: confirmation of unaffected fetuses following preimplantation genetic testing.基于细胞的单基因疾病无创性产前检测:胚胎植入前遗传学检测后未受影响胎儿的确认。
J Assist Reprod Genet. 2021 Aug;38(8):1959-1970. doi: 10.1007/s10815-021-02104-5. Epub 2021 Mar 7.
7
Syncytiotrophoblast stress in preeclampsia: the convergence point for multiple pathways.子痫前期中合体滋养层应激:多种途径的汇聚点。
Am J Obstet Gynecol. 2022 Feb;226(2S):S907-S927. doi: 10.1016/j.ajog.2020.09.047. Epub 2021 Feb 2.
8
Fetal Growth Restriction: ACOG Practice Bulletin, Number 227.胎儿生长受限:ACOG 实践通报,第 227 号。
Obstet Gynecol. 2021 Feb 1;137(2):e16-e28. doi: 10.1097/AOG.0000000000004251.
9
Imbalances in circulating angiogenic factors in the pathophysiology of preeclampsia and related disorders.循环血管生成因子失衡与子痫前期及相关疾病的病理生理学。
Am J Obstet Gynecol. 2022 Feb;226(2S):S1019-S1034. doi: 10.1016/j.ajog.2020.10.022. Epub 2020 Oct 20.
10
Commentary on a combined approach to the problem of developing biomarkers for the prediction of spontaneous preterm labor that leads to preterm birth.探讨联合应用方法预测自发性早产导致早产的生物标志物问题的述评。
Placenta. 2020 Sep 1;98:13-23. doi: 10.1016/j.placenta.2020.05.007. Epub 2020 May 25.